SCHEMBL9997608

SCHEMBL9997608

CC(=O)OC(OC(C)=O)/C(=C/c1ccccc1F)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
HIF1A Q16665 1/20 0.45
TSHR P16473 1/20 0.44
TRPA1 O75762 1/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MMP1 P03956 1/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
NPC1 O15118 2/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997610 1.00 CYP2C19 (0.45) CYP2C19CYP1A2CYP3A4CYP2C9HIF1A
SCHEMBL9997900 0.85 TSHR (0.45) CYP3A4CYP2C9TSHRALDH1A1SMN1; SMN2
SCHEMBL9997903 0.85 TSHR (0.45) CYP3A4CYP2C9TSHRALDH1A1SMN1; SMN2
SCHEMBL9998101 0.85 TRPA1 (0.48) CYP2C19CYP1A2CYP3A4CYP2C9HIF1A
SCHEMBL9998103 0.85 TRPA1 (0.48) CYP2C19CYP1A2CYP3A4CYP2C9HIF1A
SCHEMBL9997936 0.84 TSHR (0.44) CYP3A4CYP2C9TSHRCNR2ALDH1A1
SCHEMBL9997364 0.84 LMNA (0.45) TSHRALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL9997398 0.84 TSHR (0.44) CYP3A4CYP2C9TSHRALDH1A1GAA
SCHEMBL9997363 0.84 LMNA (0.45) TSHRALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL9998456 0.84 TSHR (0.44) CYP3A4CYP2C9TSHRCNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP2C19 85/4885CYP1A2 19/4885CYP3A4 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.